Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 202179

Expand all

PREDNISOLONE SODIUM PHOSPHATE (PREDNISOLONE SODIUM PHOSPHATE)
EQ 10MG BASE
Marketing Status: Discontinued

Active Ingredient: PREDNISOLONE SODIUM PHOSPHATE
Proprietary Name: PREDNISOLONE SODIUM PHOSPHATE
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A202179
Product Number: 001
Approval Date: Apr 10, 2013
Applicant Holder Full Name: RISING PHARMA HOLDINGS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

PREDNISOLONE SODIUM PHOSPHATE (PREDNISOLONE SODIUM PHOSPHATE)
EQ 15MG BASE
Marketing Status: Discontinued

Active Ingredient: PREDNISOLONE SODIUM PHOSPHATE
Proprietary Name: PREDNISOLONE SODIUM PHOSPHATE
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: EQ 15MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A202179
Product Number: 002
Approval Date: Apr 10, 2013
Applicant Holder Full Name: RISING PHARMA HOLDINGS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

PREDNISOLONE SODIUM PHOSPHATE (PREDNISOLONE SODIUM PHOSPHATE)
EQ 30MG BASE
Marketing Status: Discontinued

Active Ingredient: PREDNISOLONE SODIUM PHOSPHATE
Proprietary Name: PREDNISOLONE SODIUM PHOSPHATE
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: EQ 30MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A202179
Product Number: 003
Approval Date: Apr 10, 2013
Applicant Holder Full Name: RISING PHARMA HOLDINGS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information